Search Results 1181-1190 of 17001 for Cosmeceutical
ROCHESTER, Minn. — Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and increasingly ...
Carfilzomib is not superior to Bortezomib in delaying multiple myeloma progression after initial treatment featured image · Managing levels of specific protein, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic Minute: How personalized vaccines target cancer tumors featured image · Mayo Clinic contributes to national Alzheimer's disease research priorities ...
New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show. ROCHESTER, Minn. — In a new pilot feasibility study, ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...
The purpose of this study is to test the validity of durvalumab and VEGF inhibitor therapy to enhance anti-tumor immune responses to produce significant and ...
Latest stories · Consumer Health: 5 types of gynecologic cancer featured image · Mayo Clinic Minute: Patch testing for allergic contact dermatitis featured image.
Latest stories · Phage therapy shows potential for treating prosthetic joint infections featured image · Science Saturday: A pioneering Hispanic health conference ...
A recent Mayo Clinic study investigated how telehealth in palliative care may provide value for rural caregivers, healthcare teams and their patients. Latest ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.